Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1989 1
1990 1
1991 1
1992 1
1993 3
1994 2
1995 2
1996 4
1997 2
1998 2
1999 5
2000 4
2001 5
2002 4
2003 2
2004 3
2006 6
2007 1
2008 9
2009 2
2010 4
2011 5
2012 3
2013 4
2014 4
2015 7
2016 11
2017 9
2018 6
2019 2
2020 3
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: ichikawa w. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09.
Tsuji A, Nakamura M, Watanabe T, Manaka D, Matsuoka H, Kataoka M, Takeuchi M, Ichikawa W, Fujii M. Tsuji A, et al. Among authors: ichikawa w. Target Oncol. 2021 Nov;16(6):753-760. doi: 10.1007/s11523-021-00845-y. Epub 2021 Oct 31. Target Oncol. 2021. PMID: 34718946 Review.
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Takahashi Y, Sunakawa Y, Inoue E, Kawabata R, Ishiguro A, Kito Y, Akamaru Y, Takahashi M, Yabusaki H, Matsuyama J, Makiyama A, Tsuda M, Suzuki T, Yasui H, Matoba R, Kawakami H, Nakajima TE, Muro K, Ichikawa W, Fujii M. Takahashi Y, et al. Among authors: ichikawa w. Gastric Cancer. 2022 Jan;25(1):235-244. doi: 10.1007/s10120-021-01237-x. Epub 2021 Aug 24. Gastric Cancer. 2022. PMID: 34427838
RAS mutations in colorectal cancer.
Sunakawa Y, Lenz HJ, Ichikawa W. Sunakawa Y, et al. Among authors: ichikawa w. N Engl J Med. 2013 Nov 28;369(22):2159. doi: 10.1056/NEJMc1312697. N Engl J Med. 2013. PMID: 24283233 No abstract available.
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.
Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, Lee SW, Shibahara K, Shikano T, Kataoka M, Ishiguro A, Ojima H, Sakai Y, Musha N, Takase T, Kimura T, Takeuchi M, Fujii M. Kakeji Y, et al. Among authors: ichikawa w. Gastric Cancer. 2022 Jan;25(1):188-196. doi: 10.1007/s10120-021-01224-2. Epub 2021 Aug 5. Gastric Cancer. 2022. PMID: 34351555
115 results